Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Eye and Behçet's disease].

I Ksiaa1, N Abroug1, M Kechida2

  • 1Service d'ophtalmologie, faculté de médecine, hôpital universitaire Fattouma Bourguiba, université de Monastir, Monastir, Tunisie.

Journal Francais D'Ophtalmologie
|June 6, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Viral uveitis in the tropics].

Journal francais d'ophtalmologie·2024
Same author

[Viral and chlamydial conjunctivitis].

Journal francais d'ophtalmologie·2024
Same author

Successful management of dry eye disease with a new eye drop formulation combining hyaluronic acid, trehalose, and N-acetyl-aspartyl-glutamic acid (NAAGA).

Journal francais d'ophtalmologie·2024
Same author

[Role of optical coherence tomography in unilateral amblyopia].

Journal francais d'ophtalmologie·2023
Same author

Ocular tuberculosis presenting with a conjunctival granuloma.

Journal francais d'ophtalmologie·2023
Same author

IRVAN syndrome: A retrospective review of 9 cases from Tunisia.

Journal francais d'ophtalmologie·2022
Same journal

Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

Journal francais d'ophtalmologie·2026
Same journal

[Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

Journal francais d'ophtalmologie·2026
Same journal

Sequential dexamethasone and fluocinolone acetonide intravitreal implants to treat macular edema in non-infectious uveitis.

Journal francais d'ophtalmologie·2026
Same journal

Intravitreal anti-VEGF therapy: Comparative evaluation of appropriateness and readability of large language model chatbots' responses to frequently asked patient questions.

Journal francais d'ophtalmologie·2026
Same journal

[Trabecular surgeries in the management of glaucoma: A review of literature].

Journal francais d'ophtalmologie·2026
Same journal

Cataract surgery in eyes with nanophthalmos: Operative technique and refractive outcomes - A case series.

Journal francais d'ophtalmologie·2026
See all related articles

Behçet's disease is a chronic inflammatory condition causing vasculitis and often leading to uveitis. Understanding its autoimmune processes is key to developing targeted therapies for this multisystem disorder.

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Immunology

Background:

  • Behçet's disease is a chronic, multisystem inflammatory disorder characterized by occlusive vasculitis.
  • It disproportionately affects populations in the Mediterranean, Far East, and Middle East.
  • Clinical hallmarks include oral/genital ulcers, skin lesions, and significant systemic manifestations.

Purpose of the Study:

  • To summarize the clinical characteristics and management of Behçet's disease, with a focus on ocular involvement.
  • To highlight the importance of understanding the underlying autoimmune mechanisms for therapeutic advancement.

Main Methods:

  • Review of existing literature on Behçet's disease.
  • Analysis of clinical presentations, particularly ocular manifestations like panuveitis and retinal vasculitis.
Keywords:
Agents biologiquesBehçet's diseaseBiologicsBlindnessCorticosteroidsCorticoïdesCécitéImmunosuppressantsImmunosuppresseursMaladie de BehçetRetinal vasculitisUveitisUvéiteVasculite rétinienne

Related Experiment Videos

  • Discussion of current therapeutic strategies and future research directions.

    • Main Results:

    • Uveitis, specifically relapsing-remitting panuveitis with retinal vasculitis, is the most frequent ocular manifestation.
    • This ocular involvement can lead to severe visual impairment.
    • Current management involves corticosteroids, conventional immunosuppressants, and biologics, necessitating multidisciplinary care.

    Conclusions:

    • Effective management of Behçet's uveitis requires close collaboration between ophthalmologists and internists.
    • Further elucidation of the auto-inflammatory pathways and cytokine roles in Behçet's disease pathogenesis is crucial.
    • This understanding will pave the way for developing more specific and potent therapies.